NEWS: OCTOBER 2005

-10/21/2005-

Discovery Laboratories Inc. resubmists to the FDA NDA for Surfaxin for the prevention ofrespiratory distress syndrome in premature infants. To read article click here.

BioWa Inc. licenses Anti-FGF8 antibody from Kyowa Hakko Kogyo Co. Ltd. To read article click here.

-10/20/2005-

Press Release: Velocity-11, a supplier of pioneering automation technology solutions for life science laboratories, has recently expanded their service and technical specialist teams with staff appointments in Germany, France and the UK. To read press release click here.

FDA approves brain stem cell transplant. To read article click here.

Genentech Inc. and the Accelerate Brain Cancer Cure foundation form collaboration to study Avastin (bevacizumab) for brain cancer treatment. To read article click here.

MedImmune Inc. and Avidia Inc. form collaboration to develop anti-cancer products targeting receptor tyrosine kinase cMET in certain cancer cells. To read article click here.

Schering AG to initiate Phase III clinical trials of Sargramostim for treatment of Crohn's disease. To read article click here.

-10/19/2005-

Press Release: Radleys Discovery Technologies has announced a new range of PTFE microplates for applications including storage of diverse compound libraries, collection of aggressive chemicals and compounds as well as heated or cooled combinatorial chemistry reactions. To read press release click here.

Press Release: Genevac has released a new application report that discusses the importance of closely monitoring sample drying processes and presents solutions to save time and prevent sample loss. To read press release click here.

Kosan Biosciences Inc. halts Phase II clinical trials of KOS-862 for prostate cancer. To read article click here.

Samaritan Pharmaceuticals Inc. to publish in the Journal Pharmacology (2006, vol. 76, pages 19-33) a manuscript describing its "Alzheimer's Rat Model". To read article click here.

Cerexa Inc. initiates Phase II clinical trials of next-generation cephalosporin antibiotic PPI-0903 for the treatment against methicillin-resistant Staphylococcus aureus (MRSA). To read article click here.

FDA grants fast-track status to SGX Pharmaceuticals Inc.'s Troxatyl for third-line treatment of Acute Myeloid Leukemia (AML) in adults. To read article click here.

-10/18/2005-

Press Release: Eidogen-Sertanty Announces DirectDesign Discovery Collaboration with KAI Pharmaceuticals. To read press release click here.

Press Release: Velocity-11 has introduced the BioCel 1200, the company's newest automated sample processing platform. To read press release click here.

Serono AG settles AIDS-drug fraud case for $700M. To read article click here.

MedImmune acquires Cellective Therapeutics. To read article click here.

Novo Nordisk AS initiates Phase I clinical trials of blood-clotting protein rFXIII in patients undergoing cardiac surgery. To read article click here.

TOPIGEN Pharmaceuticals Inc. begins Phase II clinical Trials of ASM8 for asthma treatment. To read article click here.

Rigel Pharmaceuticals Inc. discovers role for the receptor tyrosine kinase Axl in angiogenesis and tumor growth. To read article click here.

-10/17/2005-

Press Release: Radleys a leading manufacturer of Controlled Laboratory Reactor systems for process development has recently announced an exclusive distribution agreement with Syrris Inc. (Ridgewood, NJ) to spearhead its North American sales and technical support. To read press release click here.

Millennium Pharmaceuticals Inc. begins combination Phase I/II clinical trials of MLN518 in acute myelogenous leukemia. To read article click here.

-10/14/2005-

Press Release: Prous Science selects ChemAxon to extend online knowledge mining functionality. To read press release click here.

Discovery Partners International Inc. sells to Nexus Biosystems Inc. its IRORI chemical synthesis systems business, the Crystal Farm automated protein crystallization business, and the Universal Store compound storage systems business. To read article click here.

-10/13/2005-

Press Release: Guava Technologies has announced a new applications note that describes a novel multiplex approach to cellular analysis using their microplate-based Guava Easycyte system. To read press release click here.

FDA gives the OK to Chiron on flue vaccine. To read article click here.

Chiron Corp. and Xoma Ltd. begin Phase I clinical trials of antagonist antibody CHIR-12.12 to treat multiple myeloma. To read article click here.

-10/12/2005-

Koronis Pharmaceuticals Inc. begins Phase 1b clinical trials of KP-1461 for HIV treatment. To read article click here.

-10/11/2005-

Praecis Pharmaceuticals Inc. to sell its HQ/R&D facility for $51.2 M. To read article click here.

Targeted Genetics Corporation begins Phase I clinical trials of tgAAC94 for arthritis. To read article click here.

Eisai Co. Ltd. and TorreyPines Therapeutics Inc. form discovery collaboration for Alzheimer's disease. To read article click here.

-10/10/2005-

Press Release: Porvair Sciences Ltd., specialists in microplate technologies offers a comprehensive range of plate sealing equipment, accessories and seals to cater for almost any requirement. To read press release click here.

Press Release: Nanion achieves outstanding rank for overall instrument performance in a recent ion channel survey by HTStec focused on real user experience of automated patch clamping ("HTStec Ion Channel Trends 2005"). To read press release click here.

-10/07/2005-

Beckman Coulter to acquire Diagnostic Systems Laboratories Inc. To read article click here.

-10/06/2005-

Telik Inc. receives FDA clearance to conduct clinical studies under new oral formulation of TELINTRA™. To read article click here.

Repligen Corporation begins Phase II clinical trials of synthetic human secretin RG1068 in patients with schizophrenia. To read article click here.

FDA grants ZymoGenetics Inc.'s Interleukin 21 (IL-21) orphan drug status for melanoma treatment. To read article click here.

-10/05/2005-

Chiron Corp. and Nektar Therapeutics initiates Phase III clinical trials of inhaled Tobramycin for cystic fibrosis. To read article click here.

FDA approves Pfizer's Aromasin® for adjuvant treatment of early breast cancer in postmenopausal women. To read article click here.

Jubilant Organosys Ltd. acquires Target Research Associates Inc. To read article click here.

ChemGenex Pharmaceuticals Limited initiates Phase II clinical trials of Ceflatonin in Gleevec-resistant chronic myeloid leukemia (CML) patients. To read article click here.

-10/04/2005-

Press Release: Porvair Sciences, a supplier of applications focused microplate technology, offers a complete range of microplate products for drug discovery laboratories. To read press release click here.

CancerVax Corp. to cut workforce more than half due to the cancelling of clinical trials of Canvaxin for skink cancer. To read article click here.

Caliper Life Sciences completes the acquisition of NovaScreen Biosciences. To read article click here.

-10/03/2005-

Press Release: Barnstead Genevac has announced a technical brochure that provides a comprehensive introduction to its recently launched miVac range of affordable centrifugal concentrators for molecular biology applications. To read press release click here.

Press Release: INTEGRA Biosciences has officially launched the MEDIAJET - a next generation system that enables automated filling of up to 540 Petri dishes at the push of a button. To read press release click here.

Angiotech Pharmaceuticals Inc. and CombinatoRx Inc. form drug discovery collaboration. To read article click here.